What Is KBC Ancora SCA's (EBR:KBCA) Share Price Doing?HomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)What Is KBC Ancora SCA's (EBR:KBCA) Share Price Doing?Simply Wall StSimply Wall St.January 6, 2020ReblogShareTweetShareView photosKBC Ancora SCA (EBR:KBCA), which is in the diversified financial business, and is based in Belgium, saw a double-digit share price rise of over 10% in the past couple of months on the ENXTBR. As a €3.6b market cap stock, it seems odd KBC Ancora is not more well-covered by analysts. However, this is not necessarily a bad thing given that there are less eyes on the stock to push it closer to fair value. Is there still an opportunity to buy? Let’s take a look at KBC Ancora’s outlook and value based on the most recent financial data to see if the opportunity still exists. See our latest analysis for KBC Ancora What's the opportunity in KBC Ancora?The stock seems fairly valued at the moment according to my valuation model. It’s trading around 13% below my intrinsic value, which means if you buy KBC Ancora today, you’d be paying a fair price for it. And if you believe that the stock is really worth €52.34, then there isn’t much room for the share price grow beyond what it’s currently trading. Furthermore, KBC Ancora’s low beta implies that the stock is less volatile than the wider market.Can we expect growth from KBC Ancora?ENXTBR:KBCA Past and Future Earnings, January 6th 2020MoreInvestors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to grow by a double-digit 16% over the next couple of years, the outlook is positive for KBC Ancora. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.What this means for you:Are you a shareholder? It seems like the market has already priced in KBCA’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?Are you a potential investor? If you’ve been keeping an eye on KBCA, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on KBC Ancora. You can find everything you need to know about KBC Ancora in the latest infographic research report. If you are no longer interested in KBC Ancora, you can use our free platform to see my list of over 50 other stocks with a high growth potential.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoInvestors ditch market risk as stocks fall into correctionReutersStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoBaidu warns of big hit from coronavirus outbreakAFPStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance